Related Experiment Video
Updated: May 29, 2026

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
Correlation between cognitive functions and nitric oxide levels in patients with dementia
Richa Sachdeva1, Rashmi Babbar, Vinod Puri
1Department of Physiology, Maulana Azad Medical College, New Delhi, India. dr_richa2811@yahoo.co.in
Abstract:
Dementia is defined as a clinical syndrome characterized by acquired loss of cognitive and emotional abilities, severe enough to interfere with daily functioning and quality of life. Event related potentials (ERP) are sensitive to task variables that relate to cognitive behavior. They might be altered in patients with disorders of cognition such as dementia. Application of the P300 ERP component to the study of cognitive disorders provides a means of quantifying the level of mental impairment. At high levels, nitric oxide (NO), which is produced by microglia due to induction of nitric oxide synthase (NOS), is neurotoxic and may play a role in neurodegeneration. In our study an attempt has been made to record ERP in patients of mild and moderate dementia and to correlate their findings with nitric oxide levels in CSF and serum. Twenty patients with dementia were selected as cases and 20 subjects as controls, which were further subdivided according to the age groups. Both dementia cases and controls were assessed by minimental state examination (MMSE) and clinical dementia rating scale (CDRS) for evaluating the degree of dementia. It was observed that the MMSE score was reduced in demented cases. P300 latency was significantly delayed in mild and moderate cases of dementia. However, no change was seen in NO levels of cerebrospinal fluid (CSF) and serum in dementia cases and controls. A negative correlation was found between MMSE and P300 latency. Hence we conclude that cognitive impairment in demented patients is reflected in P300 latency but not in NO levels in CSF and serum.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Nitric Oxide Signaling Pathway
Dementia l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Pharmacodynamics in Geriatric Patients: Effects of Age
